Michigan Automated Prescription Program 2010
(Ambassador Ballroom 2, Level 3)
112-000-10-142-L03-P & 112-000-10-842-L03-P, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Michael E. Wissel, BS. Pharm., pharmacy services manager, Bureau of Health Professions, Health Investigation Division, Lansing, Mich.
At the end of this presentation, participants should be able to identify the purpose and appropriate use of Michigan Automated Prescription Program (MAPS) data; name the most prescribed and dispensed controlled substances in Michigan; discuss the danger of methadone abuse; and explain how MAPS data is used in a proactive approach to diversion. (This program meets pharmacy law requirements for certified pharmacy technicians.)

Dilemmas with Diabetes in Various Practice Settings: Focus on Millennial Drugs and Beyond (Ambassador Ballroom 3, Level 3)
112-000-10-143-L01-P & 112-000-10-843-L01-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Application-based Activity
Justine S. Gortney, Pharm.D., BCPS, associate professor, Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Mich.; and Nicole R. Pinelli, Pharm.D., MS, CDE, assistant professor, Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Mich.
At the end of this presentation, participants should be able to describe medication-related issues of the newest medications, including amylin agonists, incretin-based therapies, new generation insulin products and drugs on the horizon for the management of diabetes in both community and inpatient settings. Participants should also be able to discuss patient goals, proper medication administration and storage, patient counseling and outcomes for specific agents; address issues in acute illness that impact use of new existing products, such as metformin, thiazolidinediones and insulin; and evaluate individual case scenerios regarding patients with diabetes in multiple settings, including the community, ambulatory clinic and hospital.

The Medication Therapy Management (MTM) Business Blueprint: Building a Profitable MTM Practice (Ambassador Ballroom 2, Level 3)
112-000-10-144-L04-P & 112-000-10-844-L04-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-base Activity
Lisa Meny, Pharm.D., assistant professor of pharmacy practice, Ferris State University College of Pharmacy, Grand Rapids, Mich.; and Anton T. Sheridan, Pharm.D., director of business development, Well Street Care Management™, Grandville, Mich.
At the end of this presentation, participants should be able to describe the four major components of the MTM business blueprint; identify the operational systems of a profitable MTM practice; discuss the value of using a systematic approach in developing an MTM practice; and create a profitable MTM practice by following the proven blueprint system.

Medical Marihuana (Ambassador Ballroom 3, Level 3)
112-000-10-145-L03-P & 112-000-10-845-L03-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Rae Ramsdell, regulatory division director, Michigan Board of Medicine, Lansing, Mich.
At the end of this presentation, participants should be able to explain the Michigan Medical Marihuana Act; identify who would be considered a qualifying patient; list the medical conditions that warrant a patients use of medical marihuana, explain the role of the primary caregiver; and discuss a pharmacy’s role according to the Act.

House of Delegates Session
2010 Pharmacy Legislative and Regulatory Trends (Ambassador Ballroom 1, Level 3)
112-000-10-136-L03-P & 112-000-10-836-L03-T, 1.0 contact hour
Harvey E. Schmidt, president, Schmidt & Sons Pharmacy; chairman, Michigan Board of Pharmacy, Tecumseh, Mich.; and Larry D. Wagenknecht, R.Ph., chief executive officer, Michigan Pharmacists Association, Lansing, Mich.
At the end of this presentation, participants should be able to discuss proposed state and federal legislation; discuss the impact of the Board of Pharmacy rule changes on the practice of pharmacy; explain how legislation may impact the profession; and discuss the role of the pharmacist to assure that patient care is enhanced. (This program meets pharmacy law requirements for certified pharmacy technicians.) Statements of credit will be awarded independently from the Annual Convention.

Right Up There with Chicken Soup: Herbal Use in the United States (Ambassador Ballroom 2, Level 3)
112-000-10-146-L01-P & 112-000-10-846-L01-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Jodie L. Elder, Pharm.D., assistant professor of pharmacy practice, Ferris State University College of Pharmacy, Grand Rapids, Mich.
At the end of this presentation, participants should be able to describe recent patterns of herbal use in the United States; identify populations that may be at increased risk of herbal-drug or herbal-disease interactions; describe use, effects and toxicity of commonly used herbs; and list available resources for safety and efficacy information of herbal medicines.

Innovations in Community Practice: Utility of Rapid Diagnostic Tests (Ambassador Ballroom 3, Level 3)
112-000-10-147-L01-P & 112-000-10-847-L01-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Application-based Activity
Jennifer K. Hagerman, Pharm.D., associate professor, Ferris State University College of Pharmacy, Linden, Mich.; Donald G. Klepser, Ph.D., assistant professor, University of Omaha Medical Center College of Pharmacy, Omaha, Neb.; Michael E. Klepser, Pharm.D., professor, Ferris State University College of Pharmacy, Kalamazoo, Mich.; and Stephanie A. Knechtel, Pharm.D., clinical pharmacist, MSU-KCMS Pharmacy, Kalamazoo, Mich.
At the end of this presentation, participants should be able to, given a diagnostic test package insert/specifications, evaluate the usefulness and reliability of the test. Participants should also be able to identify patients for whom use of a rapid diagnostic test would be appropriate and determine how the results of a test would affect patient care; construct a business plan to utilize and bill for diagnostic testing services; and describe the steps and demonstrate the technique used to conduct influenza and Group A Streptococcus rapid diagnostic tests.

How Sweet It Is: Sucrose Analgesia in Infants (Ambassador Ballroom 2, Level 3)
112-000-10-148-L01-P & 112-000-10-848-L01-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Julie B. Ryckman, Pharm.D. Candidate, Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Mich.
At the end of this presentation, participants should be able to explain the mechanism of action and pharmacology of oral sucrose, along with the experimental evidence supporting its use, and describe the circumstances in which oral sucrose is an appropriate choice to provide analgesia, including the population in which it is efficacious. Participants should also be able to describe an appropriate dosing regimen, including monitoring parameters and ways to monitor response for infants receiving oral sucrose, and discuss the long-term consequences of failing to provide adequate analgesia to infants in pain. (This program meets requirements for obtaining pain management continuing education credit for pharmacists.)

Pharmacy Ethics (Ambassador Ballroom 3, Level 3)
112-000-10-149-L03-P & 112-000-10-849-L03-T, 1.3 contact hours
Audience: Pharmacists and Pharmacy Technicians
Knowledge-based Activity
Jesse C. Vivian, R.Ph., J.D., professor, Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, Mich.
At the end of this presentation, participants should be able to define the concept of ethics, explain professional ethics, identify sources of ethical values, discuss the pharmacy code of ethics, develop problem solving techniques and examine interest of law and ethics. (This program meets pharmacy law requirements for certified pharmacy technicians.)